Spots Global Cancer Trial Database for recurrent thyroid cancer

Every month we try and update this database with for recurrent thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer	NCT00470496	Recurrent Adeno... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Thyro... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Follicu... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Papilla... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage II Adenoi... Stage II Basal ... Stage II Esthes... Stage II Follic... Stage II Invert... Stage II Lympho... Stage II Lympho... Stage II Midlin... Stage II Mucoep... Stage II Papill... Stage II Saliva... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Verruc... Stage II Verruc...	HPPH photodynamic th... conventional su...	18 Years -	Roswell Park Cancer Institute
NGR-TNF in Treating Patients With Advanced Solid Tumors	NCT00098943	Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu...	CNGRC peptide-T...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy	NCT00095836	Head and Neck C...	Gefitinib	18 Years -	Massachusetts General Hospital
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy	NCT00104871	Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill...	Bortezomib	18 Years -	National Cancer Institute (NCI)
Iodine I 131 in Treating Patients With Thyroid Cancer	NCT00416949	Head and Neck C...	Patient-specifi...	18 Years - 100 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer	NCT00470496	Recurrent Adeno... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Thyro... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Follicu... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Papilla... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage II Adenoi... Stage II Basal ... Stage II Esthes... Stage II Follic... Stage II Invert... Stage II Lympho... Stage II Lympho... Stage II Midlin... Stage II Mucoep... Stage II Papill... Stage II Saliva... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Squamo... Stage II Verruc... Stage II Verruc...	HPPH photodynamic th... conventional su...	18 Years -	Roswell Park Cancer Institute
Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer	NCT00100828	Head and Neck C...	irinotecan hydr...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases	NCT00062348	Colorectal Canc... Head and Neck C... Metastatic Canc...	boronophenylala... sodium borocapt... conventional su...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer	NCT00126568	Anaplastic Thyr... Recurrent Thyro...	sorafenib tosyl...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors	NCT00002608	Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma	cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera...	- 65 Years	National Cancer Institute (NCI)
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer	NCT04892303	Recurrent Thyro...	Combination tre...	18 Years - 85 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery	NCT01413113	Recurrent Thyro... Stage IVA Folli... Stage IVA Papil... Stage IVB Folli... Stage IVB Papil... Stage IVC Folli... Stage IVC Papil...	pazopanib hydro... iodine I 131	18 Years -	University of Washington
Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer	NCT02152137	Anaplastic Thyr... Recurrent Thyro...	efatutazone paclitaxel	18 Years -	Alliance for Clinical Trials in Oncology
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer	NCT04892303	Recurrent Thyro...	Combination tre...	18 Years - 85 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer	NCT00004062	Head and Neck C...	azacitidine liothyronine so... iodine I 131	-	National Cancer Institute (NCI)
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer	NCT00134043	Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... Thyroid Gland M...	vorinostat	18 Years -	National Cancer Institute (NCI)
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer	NCT00068497	Anaplastic Thyr... Insular Thyroid... Metastatic Para... Recurrent Adeno... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Parat... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Thyro... Recurrent Verru... Stage III Folli... Stage III Papil... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Verru... Stage IIIB Non-... Stage IV Lympho... Stage IV Non-sm... Stage IV Squamo... Stage IV Squamo... Stage IVA Adeno... Stage IVA Basal... Stage IVA Esthe... Stage IVA Folli... Stage IVA Inver... Stage IVA Lymph... Stage IVA Midli... Stage IVA Mucoe... Stage IVA Papil... Stage IVA Saliv... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Adeno... Stage IVB Basal... Stage IVB Esthe... Stage IVB Folli... Stage IVB Inver... Stage IVB Lymph... Stage IVB Midli... Stage IVB Mucoe... Stage IVB Papil... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Adeno... Stage IVC Basal... Stage IVC Esthe... Stage IVC Folli... Stage IVC Inver... Stage IVC Lymph... Stage IVC Midli... Stage IVC Mucoe... Stage IVC Papil... Stage IVC Saliv... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Thryoid Gland N... Thyroid Gland M... Tongue Cancer Untreated Metas...	gefitinib	-	National Cancer Institute (NCI)
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors	NCT00019331	Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu...	aldesleukin ras peptide can... sargramostim DetoxPC	18 Years -	National Cancer Institute (NCI)
Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer	NCT00095693	Anaplastic Thyr... Insular Thyroid... Recurrent Thyro... Stage III Folli... Stage III Papil... Stage IV Follic... Stage IV Papill...	sorafenib tosyl... laboratory biom... pharmacological... fludeoxyglucose... positron emissi... dynamic contras...	18 Years -	National Cancer Institute (NCI)
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer	NCT01118065	Head and Neck C...	everolimus	18 Years -	National Cancer Institute (NCI)
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131	NCT00085293	Recurrent Thyro... Stage IVA Folli... Stage IVA Papil... Stage IVB Folli... Stage IVB Papil... Stage IVC Folli... Stage IVC Papil...	Decitabine Iodine I 131 Recombinant thy... Fludeoxyglucose... Positron emissi...	18 Years -	National Cancer Institute (NCI)
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy	NCT00104871	Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill...	Bortezomib	18 Years -	National Cancer Institute (NCI)
Thalidomide in Treating Patients With Thyroid Cancer	NCT00026533	Head and Neck C...	thalidomide	18 Years - 120 Years	University of Kentucky
NGR-TNF in Treating Patients With Advanced Solid Tumors	NCT00098943	Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu...	CNGRC peptide-T...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Iodine I 131 in Treating Patients With Thyroid Cancer	NCT00416949	Head and Neck C...	Patient-specifi...	18 Years - 100 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer	NCT00118248	Recurrent Thyro... Stage IV Follic... Stage IV Papill... Thyroid Gland M...	tanespimycin	18 Years -	National Cancer Institute (NCI)
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy	NCT00095836	Head and Neck C...	Gefitinib	18 Years -	Massachusetts General Hospital
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer	NCT00118248	Recurrent Thyro... Stage IV Follic... Stage IV Papill... Thyroid Gland M...	tanespimycin	18 Years -	National Cancer Institute (NCI)
Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer	NCT00095693	Anaplastic Thyr... Insular Thyroid... Recurrent Thyro... Stage III Folli... Stage III Papil... Stage IV Follic... Stage IV Papill...	sorafenib tosyl... laboratory biom... pharmacological... fludeoxyglucose... positron emissi... dynamic contras...	18 Years -	National Cancer Institute (NCI)
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck	NCT00005647	Head and Neck C...	paclitaxel semaxanib	18 Years -	Case Comprehensive Cancer Center
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer	NCT00068497	Anaplastic Thyr... Insular Thyroid... Metastatic Para... Recurrent Adeno... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Parat... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Thyro... Recurrent Verru... Stage III Folli... Stage III Papil... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Verru... Stage IIIB Non-... Stage IV Lympho... Stage IV Non-sm... Stage IV Squamo... Stage IV Squamo... Stage IVA Adeno... Stage IVA Basal... Stage IVA Esthe... Stage IVA Folli... Stage IVA Inver... Stage IVA Lymph... Stage IVA Midli... Stage IVA Mucoe... Stage IVA Papil... Stage IVA Saliv... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Squam... Stage IVA Verru... Stage IVA Verru... Stage IVB Adeno... Stage IVB Basal... Stage IVB Esthe... Stage IVB Folli... Stage IVB Inver... Stage IVB Lymph... Stage IVB Midli... Stage IVB Mucoe... Stage IVB Papil... Stage IVB Saliv... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Squam... Stage IVB Verru... Stage IVB Verru... Stage IVC Adeno... Stage IVC Basal... Stage IVC Esthe... Stage IVC Folli... Stage IVC Inver... Stage IVC Lymph... Stage IVC Midli... Stage IVC Mucoe... Stage IVC Papil... Stage IVC Saliv... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Squam... Stage IVC Verru... Stage IVC Verru... Thryoid Gland N... Thyroid Gland M... Tongue Cancer Untreated Metas...	gefitinib	-	National Cancer Institute (NCI)
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer	NCT00134043	Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... Thyroid Gland M...	vorinostat	18 Years -	National Cancer Institute (NCI)
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery	NCT01413113	Recurrent Thyro... Stage IVA Folli... Stage IVA Papil... Stage IVB Folli... Stage IVB Papil... Stage IVC Folli... Stage IVC Papil...	pazopanib hydro... iodine I 131	18 Years -	University of Washington
Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer	NCT00061906	Head and Neck C...	celecoxib	18 Years -	Ohio State University Comprehensive Cancer Center
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer	NCT01164176	Head and Neck C...	everolimus laboratory biom...	18 Years -	Yonsei University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: